Radiofrequency ablation of hepatocellular carcinoma: Predicting success using contrast-enhanced sonography

American Journal of Roentgenology

Volumn 186, Issue 5 SUPPL., 2006, Pages

  Dill Macky, Marcus J ^a,b   Asch, Murray ^a   Burns, Peter ^c   Wilson, Stephanie ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Ablation; Contrast media; Interventional radiology; Liver; Radiofrequency; Sonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOLOGIST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846307453     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.1916     Document Type: Article

References (31)

1. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001; 26:345-360
2. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR 2000; 174:323-331
3. Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J 2000; 6[suppl 4]:S304-S315
4. Goldberg SN, Gazelle GS, Dawson SL, et al. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2:399-404
5. Goldberg SN, Gazelle GS, Halpern EF, et al. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3:212-218
6. Goldberg SN, Hahn PF, Halpern EF, et al. Radiofrequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209:761-767
7. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203
8. Raman SS, Lu DS, Vodopich DJ, et al. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR 2000; 175:1253-1258
9. Cha CH, Lee FT, Gurney JM, et al. CT versus sonography for monitoring radiofrequency ablation in a porcine liver. AJR 2000; 175:705-711
10. Kim SK, Lim HK, Kin YH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. RadioGraphics 2003; 23:107-121
11. Liamanond P, Zimmerman P, Raman SS, et al. Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR 2003; 181:1635-1640
12. Sironi S, Livraghi T, Meloni F, et al. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR 1999; 173:1225-1229
13. Dill-Macky MJ, Burns PN, Khalili K, et al. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US Radiology 2002; 222:95-102
14. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35:58-71
15. Chan RP, Asch M, Kachura J, et al., Radiofrequency ablation of malignant hepatic neoplasms. Can Assoc Radiol J 2002; 53:272-278
16. Bonny C, Abergel A, Gayard P, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis. Gastroenterol Clin Biol 2002; 26:735-741
17. Skjoldbye B, Burcharth F, Christensen JK, et al. Ultrasound-guided radiofrequency ablation of malignant liver tumors [in Danish]. Ugeskr Laeger 2002; 164:4646-4650
18. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-391
19. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response - preliminary results. Radiology 2000; 217:558-563
20. Foster FS, Burns PN, Simpson DH, et al. Ultrasound for the visualization and quantification of tumor microcirculation. Cancer Metastasis Rev 2000; 19:131-138
21. Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology. 2000; 215:153-161
22. Vallone P, Gallipoli A, Izzo F, et al. Local ablation procedures in primary liver tumors: Levovist US versus spiral CT to evaluate therapeutic results. Anticancer Res 2003; 23:5075-5079
23. Vilana R, Llovet JM, Bianchi L, et al. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. J Clin Ultrasound 2003; 31:119-128
24. Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR 2001; 177:783-788
25. Albrecht T, Hoffmann CW, Schmitz S A, et al. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR 2001; 176:1191-1198
26. Hohmann J, Albrecht T, Hoffmann CW, et al. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol 2003; 46:147-156
27. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR 2001; 177:375-380
28. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR 2003; 181:57-63
29. Fujita T, Honjo K, Matsumoto T, et al. High resolution dynamic MR imaging of hepatocellular carcinoma with a phased-array body coil. RadioGraphics 1997; 17:315-331
30. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. AJR 1998; 170:1023-1028
31. Solbiati L, Ierace T, Tonolini M, et al. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51[suppl]:S19-S23